(Q35728321)

9 August 2017

title

The benefits of valsartan in the treatment of heart failure: results from Val-HeFT. (English)

1 reference

9 August 2017

Tan LB

1

1 reference

9 August 2017

Schlosshan D

series ordinal

2

1 reference

9 August 2017

Williams SG

series ordinal

3

1 reference

9 August 2017

language of work or name

1 reference

1 February 2004

1 reference

International Journal of Clinical Practice

9 August 2017

published in

1 reference

9 August 2017

volume

58

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

184-191

1 reference

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0134.X

Cardiac myocyte necrosis induced by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0134.X

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0134.X

Demographics, Treatment Regimens and the Use of Angiotensin-Receptor Blockers in Heart Failure: Findings from the Valsartan Heart Failure Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0134.X

10.1111/J.1368-5031.2004.0134.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference